Meconium ileus is a condition that affects newborns and can cause blockage in the intestines due to thick, sticky meconium. It is commonly associated with cystic fibrosis, a genetic disorder that affects the production of mucous in the body. Other conditions that may be mistaken for meconium ileus include Hirschsprung’s disease and meconium plug syndrome. The likelihood of a baby developing meconium ileus is not influenced by factors such as conception through IVF, family history of inflammatory bowel disease or coeliac, or delivery by caesarian section.

Cystic Fibrosis: Symptoms and Characteristics

Cystic fibrosis is a genetic disorder that affects various organs in the body, particularly the lungs and digestive system. The symptoms of cystic fibrosis can vary from person to person, but there are some common features that are often present. In the neonatal period, around 20% of infants with cystic fibrosis may experience meconium ileus, which is a blockage in the intestine caused by thick, sticky mucous. Prolonged jaundice may also occur, but less commonly. Recurrent chest infections are a common symptom, affecting around 40% of patients. Malabsorption is another common feature, with around 30% of patients experiencing steatorrhoea (excessive fat in the stool) and failure to thrive. Liver disease may also occur in around 10% of patients.

It is important to note that while many patients are diagnosed with cystic fibrosis during newborn screening or early childhood, around 5% of patients are not diagnosed until after the age of 18. Other features of cystic fibrosis may include short stature, diabetes mellitus, delayed puberty, rectal prolapse (due to bulky stools), nasal polyps, male infertility, and female subfertility. Overall, the symptoms and characteristics of cystic fibrosis can vary widely, but early diagnosis and treatment can help manage the condition and improve quality of life.

Physiological Jaundice in Infants

Physiological jaundice is a common occurrence in newborns, affecting around 90% of infants. It typically appears after the first two to three days of life and is caused by an increase in the breakdown of red blood cells and the relative immaturity of the liver. This type of jaundice is not usually a cause for concern and will often resolve on its own within a few weeks. However, if anemia is present, it may indicate a more serious underlying condition, such as hemolytic anemia. It is important for healthcare providers to monitor newborns for signs of jaundice and to investigate any potential underlying causes.

Common Pediatric Gastrointestinal Disorders

Pyloric Stenosis
Pyloric stenosis is a condition that typically affects infants between 2 and 4 weeks of age, with boys being more commonly affected. The main symptom is projectile vomiting of non-bile-stained vomit, leading to a characteristic hypochloremic, hypokalemic metabolic alkalosis.

Intussusception
Intussusception is a condition that affects approximately 1 in 500 children, usually between 6 and 18 months of age. It is often associated with viral gastroenteritis. Unlike pyloric stenosis, vomiting is not a predominant feature, and if it occurs, it may be bile-stained. Intussusception causes small bowel obstruction, leading to engorgement of the intussuscepted bowel, rectal bleeding, and possible bowel gangrene.

Biliary Atresia
Biliary atresia is a rare birth defect with a prevalence of 0.5-0.8 per 10,000 births. It causes clinical jaundice with conjugated bilirubinemia. Surgical treatment, such as a Kasai portoenterostomy, is necessary, and outcomes are generally good.

Hirschsprung’s Disease
Hirschsprung’s disease is a condition that affects approximately 1 in 5000 live births. It may be familial and is associated with trisomy 21. It typically presents within the first few days of life with intestinal obstruction. The diagnosis is confirmed through rectal biopsy.

Tracheo-Oesophageal Fistula
Tracheo-oesophageal fistula is a condition that is usually associated with oesophageal atresia but can occur on its own. It tends to present with choking or coughing during feeding and recurrent lower respiratory tract infections. Projectile vomiting is not a common feature, and the diagnosis may not be made until later in childhood.

Kawasaki disease is a systemic vasculitis that typically affects children under the age of 5. Symptoms include a fever lasting over 5 days, bilateral non-purulent conjunctivitis, a rash, mucosal erythema with a strawberry tongue, and unilateral cervical lymphadenopathy. In some cases, swelling of the hands and feet can occur, followed by desquamation in the second week. If left untreated, up to one-quarter of patients can develop coronary aneurysms. The main goal of treatment is to reduce the risk of cardiac complications. In the UK, the standard treatment is intravenous immunoglobulin and high dose aspirin, despite the fact that aspirin is usually contraindicated in children. Benzylpenicillin is not indicated in the treatment of Kawasaki disease. Conservative management is also not appropriate, as specific treatment is required to reduce inflammation and prevent the risk of coronary complications. Corticosteroids may be used as a second-line treatment if the patient does not respond to intravenous immunoglobulins.

Understanding Kawasaki Disease

Kawasaki disease is a rare type of vasculitis that primarily affects children. It is important to identify this disease early on as it can lead to serious complications, such as coronary artery aneurysms. The disease is characterized by a high-grade fever that lasts for more than five days and is resistant to antipyretics. Other symptoms include conjunctival injection, bright red, cracked lips, strawberry tongue, cervical lymphadenopathy, and red palms and soles that later peel.

Diagnosis of Kawasaki disease is based on clinical presentation as there is no specific diagnostic test available. Management of the disease involves high-dose aspirin, which is one of the few indications for aspirin use in children. Intravenous immunoglobulin is also used as a treatment option. Echocardiogram is the initial screening test for coronary artery aneurysms, rather than angiography.

Complications of Kawasaki disease can be serious, with coronary artery aneurysm being the most common. It is important to recognize the symptoms of Kawasaki disease early on and seek medical attention promptly to prevent potential complications.

Patients with VSD may require surgical intervention if their defect causes haemodynamic instability, while those with small shunts may not require treatment. However, all patients with VSD are at an increased risk of developing endocarditis, with a rate of 2.4 cases per 1000 patients per year. While pulmonary hypertension is common in patients with VSD, they are not at a higher risk of developing essential hypertension. Although VSD is associated with aneurysms of the ventricular septum, there is no known link to aortic aneurysms, carotid dissection, or papillary muscle atrophy.

Congenital heart disease can be categorized into two types: acyanotic and cyanotic. Acyanotic heart diseases are more common and include ventricular septal defects (VSD), atrial septal defect (ASD), patent ductus arteriosus (PDA), coarctation of the aorta, and aortic valve stenosis. VSD is the most common acyanotic heart disease, accounting for 30% of cases. ASDs are less common than VSDs, but they are more frequently diagnosed in adult patients as they tend to present later. On the other hand, cyanotic heart diseases are less common and include tetralogy of Fallot, transposition of the great arteries (TGA), and tricuspid atresia. Fallot’s is more common than TGA, but TGA is the more common lesion at birth as patients with Fallot’s generally present at around 1-2 months. The presence of cyanosis in pulmonary valve stenosis depends on the severity and any other coexistent defects.

The appropriate action for a child with bronchiolitis is to admit them for supportive treatment, as antibiotics are not necessary. This condition is typically caused by RSV and can be managed with supportive care. However, if the child is experiencing severe respiratory distress and a significant reduction in feeding, they should be admitted to the hospital for treatment. Admitting for IV antibiotics would not be appropriate unless pneumonia or another bacterial infection was suspected. Salbutamol nebulisers are not typically effective for bronchiolitis. Discharging the child home with advice or oral antibiotics would not be appropriate if they are showing signs of potentially serious illness.

Bronchiolitis is a condition where the bronchioles become inflamed, and it is most commonly caused by respiratory syncytial virus (RSV). This virus is responsible for 75-80% of cases, with other causes including mycoplasma and adenoviruses. Bronchiolitis is most prevalent in infants under one year old, with 90% of cases occurring in those aged 1-9 months. The condition is more serious in premature babies, those with congenital heart disease or cystic fibrosis. Symptoms include coryzal symptoms, dry cough, increasing breathlessness, and wheezing. Hospital admission is often necessary due to feeding difficulties associated with increasing dyspnoea.

Immediate referral is recommended if the child has apnoea, looks seriously unwell, has severe respiratory distress, central cyanosis, or persistent oxygen saturation of less than 92% when breathing air. Clinicians should consider referral if the child has a respiratory rate of over 60 breaths/minute, difficulty with breastfeeding or inadequate oral fluid intake, or clinical dehydration. Immunofluorescence of nasopharyngeal secretions may show RSV, and management is largely supportive. Humidified oxygen is given via a head box if oxygen saturations are persistently low, and nasogastric feeding may be necessary if children cannot take enough fluid/feed by mouth. Suction may also be used for excessive upper airway secretions. NICE released guidelines on bronchiolitis in 2015 for more information.

Innocent murmurs are common in children and are usually harmless. There are different types of innocent murmurs, including ejection murmurs, venous hums, and Still’s murmur. Ejection murmurs are caused by turbulent blood flow at the outflow tract of the heart, while venous hums are due to turbulent blood flow in the great veins returning to the heart. Still’s murmur is a low-pitched sound heard at the lower left sternal edge.

An innocent ejection murmur is characterized by a soft-blowing murmur in the pulmonary area or a short buzzing murmur in the aortic area. It may vary with posture and is localized without radiation. There is no diastolic component, no thrill, and no added sounds such as clicks. The child is usually asymptomatic, and there are no other abnormalities.

Overall, innocent murmurs are not a cause for concern and do not require treatment. However, if a child has symptoms such as chest pain, shortness of breath, or fainting, further evaluation may be necessary to rule out any underlying heart conditions.

The child’s capillary refill time is normal, as it falls within the acceptable range of less than 3 seconds. However, his tachycardia is a cause for concern, as a heart rate over 160 bpm is considered an amber flag for his age. Although reduced skin turgor is not mentioned, it would be considered a red flag indicating severe dehydration and poor circulation according to the NICE traffic light system. As the child is older than 3 months, a temperature above 38˚C would not be considered a red flag.

The NICE Feverish illness in children guidelines were introduced in 2007 and updated in 2013. These guidelines use a ‘traffic light’ system to assess the risk of children under 5 years old presenting with a fever. It is important to note that these guidelines only apply until a clinical diagnosis of the underlying condition has been made. When assessing a febrile child, their temperature, heart rate, respiratory rate, and capillary refill time should be recorded. Signs of dehydration should also be looked for. Measuring temperature should be done with an electronic thermometer in the axilla if the child is under 4 weeks old or with an electronic/chemical dot thermometer in the axilla or an infrared tympanic thermometer.

The risk stratification table includes green for low risk, amber for intermediate risk, and red for high risk. The table includes categories such as color, activity, respiratory, circulation and hydration, and other symptoms. If a child is categorized as green, they can be managed at home with appropriate care advice. If they are categorized as amber, parents should be provided with a safety net or referred to a pediatric specialist for further assessment. If a child is categorized as red, they should be urgently referred to a pediatric specialist. It is important to note that oral antibiotics should not be prescribed to children with fever without an apparent source, and a chest x-ray does not need to be routinely performed if a pneumonia is suspected but the child is not going to be referred to the hospital.

Mebendazole is the recommended first-line treatment for threadworm infestations. This particular case presents with typical symptoms of a threadworm infection, which is a common helminth in children. The infection is usually acquired through the ingestion of eggs found in the environment, often from touching soil and then putting hands in the mouth. While the infection is often asymptomatic, it can cause perianal itching, especially at night. Diagnosis is often made empirically, and treatment typically involves hygiene recommendations and mebendazole.

Diethylcarbamazine is an anti-helminthic medication used to treat filarial infections, such as those caused by Wuchereria bancrofti (which can lead to elephantiasis) and Toxocara canis (which can cause visceral larva migrans and retinal granulomas).

Ivermectin is another antiparasitic drug, but it is used to treat Strongyloides stercoralis infections, which can cause symptoms such as diarrhea, abdominal pain, and papulovesicular lesions where the skin has been penetrated by infective larvae.

Metronidazole, on the other hand, is an antibiotic used to treat a variety of bacterial infections, such as gingivitis, pelvic inflammatory disease, syphilis, and bacterial vaginosis. It is not effective in treating threadworms.

Threadworm Infestation in Children

Threadworm infestation, caused by Enterobius vermicularis or pinworms, is a common occurrence among children in the UK. The infestation happens when eggs present in the environment are ingested. In most cases, threadworm infestation is asymptomatic, but some possible symptoms include perianal itching, especially at night, and vulval symptoms in girls. Diagnosis can be made by applying Sellotape to the perianal area and sending it to the laboratory for microscopy to see the eggs. However, most patients are treated empirically, and this approach is supported in the CKS guidelines.

The CKS recommends a combination of anthelmintic with hygiene measures for all members of the household. Mebendazole is the first-line treatment for children over six months old, and a single dose is given unless the infestation persists. It is essential to treat all members of the household to prevent re-infection. Proper hygiene measures, such as washing hands regularly, keeping fingernails short, and washing clothes and bedding at high temperatures, can also help prevent the spread of threadworm infestation.

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at certain intervals. At 12-13 months, the Hib/Men C, MMR, and PCV vaccines are given, along with Men B. At 3-4 years, the ‘4-in-1 preschool booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine will also be offered to new students (up to the age of 25 years) at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine. Students going to university or college for the first time as freshers, including overseas and mature students up to the age of 25, should contact their GP to have the Men ACWY vaccine, ideally before the start of the academic year.

It is worth noting that the Men C vaccine used to be given at 3 months but has now been discontinued. This is because the success of the Men C vaccination programme means there are almost no cases of Men C disease in babies or young children in the UK any longer. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.